Annuaire
Vous pouvez découvrir dans cet annuaire les startups et scaleups de l'IA Générative détectées par Motherbase. Elles sont classées par ordre alphabétique.
- Vous pouvez les sélectionner en fonction de leur domaine technologique dans le menu ci-dessus.
- Dans le moteur de recherche ci-dessous, vous pouvez faire une recherche des mots clefs présents dans les propositions de valeur des solutions. (Attention ! Celles-ci sont en anglais).
- tous les "tags" sont des fiches sont "cliquables". Vous pouvez donc "naviguer" en sélectionnant les tags par technologie ou par secteur, ...
Et toutes les remarques et suggestions sont les bienvenues.
- Vous pouvez les sélectionner en fonction de leur domaine technologique dans le menu ci-dessus.
- Dans le moteur de recherche ci-dessous, vous pouvez faire une recherche des mots clefs présents dans les propositions de valeur des solutions. (Attention ! Celles-ci sont en anglais).
- tous les "tags" sont des fiches sont "cliquables". Vous pouvez donc "naviguer" en sélectionnant les tags par technologie ou par secteur, ...
Et toutes les remarques et suggestions sont les bienvenues.
Absci
Creating Drugs at the Speed of Ai Absci is a generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Drug CreationTM platform unlocks the potential to accelerate time to clinic and increase the probability of success by … [voir plus]
Antiverse
Designing functional antibodies for the most challenging targets. Antiverse is a Welsh techbio company specialising in antibody design for challenging drug targets, such as GPCRs and ion channels. We exist to create new enabling technologies that bring new therapies to patients to change lives. Headquartered in Cardiff, UK and with … [voir plus]
AQEMIA
Scale Drug Discovery with Quantum-inspired Physics and AI AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug candidates for dozens of critical diseases, such as immuno-oncology. Our unique approach leverages quantum-inspired physics algorithms to power generative … [voir plus]
Atomic AI
Rational design of new molecules and medicines, enabled by the fusion of artificial intelligence and structural biology. Atomic AI is a well-funded, early-stage biotech company transforming the rational design of molecules and medicines through the cutting-edge fusion of artificial intelligence and structural biology. Atomic’s unique R&D platform, based on research … [voir plus]
BigHat Biosciences
BigHat Biosciences is a novel protein therapeutics company and developer of an AI-guided antibody design platform BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to … [voir plus]
Generate:Biomedicines
Pioneering generative biology to create breakthrough therapeutics. Pioneering generative biology to create breakthrough therapeutics. [voir plus]
Insilico Medicine
#insilicomeds, #drugdiscovery, #ai, #GANs, #GANs-RL, #DL #aging, #longevity Insilico Medicine, a clinical stage biotech company powered by generative AI, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning … [voir plus]
JURA Bio, Inc.
Building the future of cell-based therapies. CAR-T is for more than just oncology. Using the full potential of gene editing, we are creating a therapeutic platform for cell based therapies that are not just disease modifying: they are curative and definitive. Cell-based Therapies and Machine Learning [voir plus]
Menten AI
Building the world's most advanced generative AI platform for peptide therapeutics design. Menten AI is a drug discovery company focused on designing peptides for conditions with high unmet medical need. We are developing the world's most advanced generative AI platform for peptide therapeutics. [voir plus]
Paige
Bridging Vision & Precision Paige is using the power of AI to drive a new era of cancer discovery and treatment. To improve the lives of patients with cancer, Paige has created a cloud-based platform that transforms pathologists’ workflow and increases diagnostic confidence as well as productivity, all on a … [voir plus]
Profluent
Decoding the language of life with AI Profluent is an AI-first protein design company. Founded in 2022, we develop deep generative models to design and validate novel, functional proteins to revolutionize biomedicine. Based in Berkeley, CA, we are backed by leading investors including Spark Capital, Insight Partners, Air Street Capital, … [voir plus]
Redesign Science
Biology Simulated Founded in 2017, Redesign Science is a platform biotech working at the interface of physics-based molecular simulation and deep learning to create generative AI for drug discovery. We deploy our platform technology to develop first-in-class Protein Interaction Modulators against validated targets known to drive progression of multiple oncogenic … [voir plus]
Syntegra
Democratizing healthcare data to dramatically accelerate how treatments reach patients. Syntegra is unlocking the promise of real-world evidence by employing a groundbreaking machine learning model — the Syntegra Medical Mind — to enable low-burden access to privacy-preserved and equitable synthetic health data, increasing the value of data for those who … [voir plus]